Harnessing Hafnium‐Based Nanomaterials for Cancer Diagnosis and Therapy

Abstract With the rapid development of nanotechnology and nanomedicine, there are great interests in employing nanomaterials to improve the efficiency of disease diagnosis and treatment. The clinical translation of hafnium oxide (HfO 2 ), commercially namedas NBTXR3, as a new kind of nanoradiosensitizer for radiotherapy (RT) of cancers has aroused extensive interest in researches on Hf‐based nanomaterials for biomedical application. In the past 20 years, Hf‐based nanomaterials have emerged as potential and important nanomedicine for computed tomography (CT)‐involved bioimaging and RT‐associated cancer treatment due to their excellent electronic structures and intrinsic physiochemical properties. In this review, a bibliometric analysis method is employed to summarize the progress on the synthesis technology of various Hf‐based nanomaterials, including HfO 2 , HfO 2 ‐based compounds, and Hf‐organic ligand coordination hybrids, such as metal‐organic frameworks or nanoscaled coordination polymers. Moreover, current states in the application of Hf‐based CT‐involved contrasts for tissue imaging or cancer diagnosis are reviewed in detail. Importantly, the recent advances in Hf‐based nanomaterials‐mediated radiosensitization and synergistic RT with other current mainstream treatments are also generalized. Finally, current challenges and future perspectives of Hf‐based nanomaterials with a view to maximize their great potential in the research of translational medicine are also discussed.